Power Over Uncertainty

HFMA’s Chad Mulvany provides insight on the Trump Administration’s June 24 executive order aimed at improving price and quality transparency.

Hospital executives say results of a new HFMA study are true: A range of higher-profile priorities, including simple survival, has kept their organizations from improving their cost-accounting abilities for almost a decade.

Healthcare organizations that qualify as HIPAA covered entities should take five steps when developing a compliance program designed to meet their obligation under HIPAA to safeguard patients’ protected health information.

The potential costs of being found noncompliant with HIPAA are too great for a healthcare provider organization not to have in place a compliance program designed to help safeguard patients’ protected health information.

Details about the new five-year mandatory radiation therapy model released by CMS the week of July 8 are reviewed.

In the face of recent, multiple setbacks on the Trump administration’s proposals for drug pricing, the administration could move aggressively forward on its anticipated International Pricing Index Model for Part B drugs proposal.

Humana may be a more desirable partner for physicians interested in risk arrangements if its collaboration with Epic reduces potentially preventable ED and inpatient utilization due to increased medication adherence.

Healthcare organizations should develop IT plans, measure themselves against their plans and consistently review how regulatory and product changes mandate the need for plan revisions.